More work is required to determine correlates of KLF4 dependence, such as patient sex, tumor location, or specific genomic/epigenomic alterations (i.e. amplification of MYC, mutations in TP53, specific variant enhancers, etc.). This evidence concerns the gene KLF4 and neoplasm.